Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2602966B2 - Method for producing silicon complex protein and silicon complex polysaccharide protein - Google Patents
[go: Go Back, main page]

JP2602966B2 - Method for producing silicon complex protein and silicon complex polysaccharide protein - Google Patents

Method for producing silicon complex protein and silicon complex polysaccharide protein

Info

Publication number
JP2602966B2
JP2602966B2 JP1319458A JP31945889A JP2602966B2 JP 2602966 B2 JP2602966 B2 JP 2602966B2 JP 1319458 A JP1319458 A JP 1319458A JP 31945889 A JP31945889 A JP 31945889A JP 2602966 B2 JP2602966 B2 JP 2602966B2
Authority
JP
Japan
Prior art keywords
silicon
protein
silicon complex
complex
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1319458A
Other languages
Japanese (ja)
Other versions
JPH03180191A (en
Inventor
悌治郎 大村
音吉 菅沼
浩明 前田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP1319458A priority Critical patent/JP2602966B2/en
Publication of JPH03180191A publication Critical patent/JPH03180191A/en
Application granted granted Critical
Publication of JP2602966B2 publication Critical patent/JP2602966B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】 〔技術分野〕 本発明は新規な抗変異原性物質(desmutagen)である
珪素複合蛋白質及び珪素複合多糖蛋白質の製造方法に関
し、より詳しくはアスペルギルス属又はレンティナス属
(シイタケ)から選ばれた糸状菌の代謝を利用して珪素
を資化させ、抗変異原性を有する珪素複合蛋白質及び珪
素複合多糖蛋白質を製造する方法に関する。
Description: TECHNICAL FIELD The present invention relates to a method for producing a novel antimutagenic substance, a silicon complex protein and a silicon complex polysaccharide protein, and more particularly to a genus Aspergillus or Lentinus (Shiitake). The present invention relates to a method for assimilating silicon by utilizing the metabolism of a filamentous fungus selected from the group, and producing a silicon complex protein and a silicon complex polysaccharide protein having antimutagenic properties.

〔発明の背景〕[Background of the Invention]

医療技術の進歩は感染症による死亡率を低下させ、日
本人の平均寿命は世界の最上位に位置づけられる程の伸
びをみせている。
Advances in medical technology have reduced mortality from infectious diseases, and the average life expectancy of Japanese has grown to be ranked at the top of the world.

しかし、癌による死亡数は相変らず増加し1980年には
脳欠陥障害を抜いて死因の第一位となり、このまま推移
すると21世紀に入る頃には死亡者の2人に1人が癌によ
って死亡するものと考えられている。癌の発生原因は未
だ不確定の要素もあるが、80〜90%は化学物質であり、
残りの10〜20%がウイルス等の生物学的因子や紫外線等
の物理的因子によるものと考えられている。
However, the number of deaths from cancer continued to increase, surpassing the brain defect disorder in 1980, becoming the number one cause of death, and if this trend continues, by the turn of the 21st century, one in two people will die from cancer. It is believed to die. The causes of cancer are still uncertain, but 80-90% are chemicals,
It is thought that the remaining 10 to 20% is due to biological factors such as viruses and physical factors such as ultraviolet rays.

化学発癌物質の多くは食品や大気等の生活環境中に存
在している。これらの化学発癌物質から身をまもること
は癌を予防する有効な方法である。
Many chemical carcinogens are present in living environments such as food and air. Protecting from these chemical carcinogens is an effective way to prevent cancer.

食品や嗜好品中にはこれら化学発癌物質が存在し、我
々は日常の食生活の中で摂取し続けている。一方、食品
中にはこれらを無毒化する物質も存在していることが確
認されている。
These chemical carcinogens are present in foods and luxury goods and we continue to consume them in our daily diet. On the other hand, it has been confirmed that substances that detoxify these exist in foods.

本発明者らは人体に悪影響を与えず、広く化学発癌物
質を無毒化する物質が存在し、その物質を日常の食生活
の中で充分摂取すれば、発癌率を相当高率に低下させる
ことができるという考えのもとに研究を進めた。
The present inventors have a substance that does not adversely affect the human body and widely detoxifies chemical carcinogens, and if the substance is sufficiently ingested in a daily diet, the carcinogenesis rate can be reduced to a considerably high rate. I researched on the idea that I can do it.

〔発明の目的及び構成〕[Object and structure of the invention]

そこで本発明者等は生活環境中に存在する化学発癌物
質を無毒化する物質或はかかる物質からなり安全で日
常、食品として摂取できる抗変異原性食品を提供するこ
とを目的として鋭意研究を重ねた。
Therefore, the present inventors have conducted intensive studies with the aim of providing a substance that detoxifies a chemical carcinogen existing in the living environment or an anti-mutagenic food made of such a substance that is safe and can be ingested daily. Was.

その結果、食品中に比較的多く含有されるミネラルで
あり、安全性が高く、典型的な半導体であることから、
生体における酸化、還元反応の触媒的作用を有すると考
えられる珪素を一般に食品又は食品製造に用いられるア
スペルギルス属又はレンティナス属(シイタケ)から選
ばれた糸状菌の代謝を利用して資化したところ、広い範
囲の化学発癌物質に対し抗変異原性活性を有する物質が
得られることを見出し、珪素としては特に錯体の有機珪
素を用いることにより安定性が高く、活性の強い物質が
得られることを確認し、本発明を完成した。
As a result, it is a mineral that is relatively high in foods, is highly safe, and is a typical semiconductor,
Oxidation in the living body, assimilation utilizing the metabolism of filamentous fungi selected from the genus Aspergillus or Lentinus (Shiitake) generally used for food or food production, which is considered to have a catalytic action of the reduction reaction, It has been found that a substance having anti-mutagenic activity can be obtained for a wide range of chemical carcinogens, and it has been confirmed that a highly stable and highly active substance can be obtained by using complex organosilicon, especially as silicon. Thus, the present invention has been completed.

かくて本発明は、珪素をアスペルギルス属又はレンテ
ィナス属(シイタケ)から選ばれた糸状菌の培養液中で
資化することを特徴とする珪素複合蛋白質及び珪素複合
多糖蛋白質の製造方法を提供するものである。
Thus, the present invention provides a method for producing a silicon-complex protein and a silicon-complex polysaccharide protein, wherein silicon is assimilated in a culture solution of a filamentous fungus selected from the genus Aspergillus or Lentinus (Shitatake). It is.

〔発明の具体的説明〕[Specific description of the invention]

本発明の珪素複合蛋白質及び珪素複合多糖蛋白質の方
法を以下に具体的に説明する。
The method for the silicon complex protein and the silicon complex polysaccharide protein of the present invention will be specifically described below.

本発明では、上述のように珪素をアスペルギルス属又
はレンティナス属(シイタケ)から選ばれた糸状菌の培
養液中で資化するのである。
In the present invention, as described above, silicon is assimilated in a culture solution of a filamentous fungus selected from the genus Aspergillus or the genus Lentina (Shitake).

この珪素としては各種化合物を使用することができる
が、本発明では特にその有機錯塩を使用するのが好まし
く、例えば、β−カルボキシエチルシリコンセスキオキ
サイドが好んで用いられる。この有機珪素錯塩は(SiCH
2CH2COOH)2O3の分子式を有しており、特開昭56−18992
号公報にその製造方法が詳しく記載されている。この化
合物は生体細胞に対する親和性に優れ、抗変異原活性が
強く、また、製造費も低廉であり、通常、綺麗な結晶の
形で製造することができる。
As the silicon, various compounds can be used. In the present invention, it is particularly preferable to use the organic complex salt thereof. For example, β-carboxyethyl silicon sesquioxide is preferably used. This organosilicon complex (SiCH
2 CH 2 COOH) 2 O 3 , which is disclosed in JP-A-56-18992.
Japanese Patent Application Laid-Open Publication No. HEI 7-209139 describes the manufacturing method in detail. This compound has excellent affinity for living cells, strong antimutagenic activity, and low production cost, and can usually be produced in the form of a beautiful crystal.

本発明において用いられるアスペルギルス属又はレン
ティナス属(シイタケ)から選ばれた糸状菌としては、
特に、Asp.Oryzae(コウジカビ)、Asp.niger(黒コウ
ジカビ)、L.Edodes(シイタケ)等が好んで用いられ
る。
As the filamentous fungus selected from the genus Aspergillus or Lentinus (Shiitake) used in the present invention,
In particular, Asp.Oryzae (Aspergillus), Asp.niger (Black Aspergillus), L.Edodes (Shiitake) and the like are preferably used.

このような珪素、特に有機珪素錯塩をアルペルギルス
属又はレンティナス属(シイタケ)から選ばれた糸状菌
の培養液で夫々適当なpH、温度にて約15日間培養して資
化する。
Such silicon, particularly an organosilicon complex, is assimilated by culturing in a culture solution of a filamentous fungus selected from the genus Alpergillus or Lentina (Shitatake) at an appropriate pH and temperature for about 15 days.

例えば、次の(1)及び(2)のような培養液でAsp.
OryzaeとL.Edodesを夫々培養して珪素を資化する。
For example, the following culture solutions (1) and (2) are used for Asp.
Oryzae and L. Edodes are each cultured to assimilate silicon.

ここで用いられる珪素錯塩は上述したβ−カルボキシ
エチルシリコンセスキオキサイドである。
The silicon complex salt used here is the above-mentioned β-carboxyethyl silicon sesquioxide.

(1) Asp.Oryzaeによる珪素の資化 培地組成 glucose 100g ペプトン 6g KH2PO4 0.1g MgSO4・7H2O 0.1g NaCl 少量 CaCl2 少量 FeCl3 少量 珪素錯塩 5g 水 1リットル 培地pH:3.0 培養条件:30℃、15日間 (2) L.Edodesによる珪素の資化 培地組成 麦芽エキス 100g 酵母エキス 2.5g 酒石酸アンモン 2.0g 珪素錯塩 5g 水 1リットル 培地pH:4.5 培養条件:20℃、15日間 培養終了後、菌体と培養瀘液を分離し、菌体は凍結粉
砕した後に水を加え、撹拌抽出し不溶物を遠心分離し除
去する。遠心上澄に硫酸アンモンを50%飽和となるよう
加え、沈殿を作出する。沈殿を遠心分離し、乾燥するこ
とにより珪素複合蛋白質の粉末を得る。一方、瀘液に2
倍容量のエタノールを加えて、沈殿を形成させ瀘別乾燥
し、珪素複合多糖蛋白質の粉末を得る。
(1) Assimilation of silicon by Asp.Oryzae Medium composition glucose 100 g peptone 6 g KH 2 PO 4 0.1 g MgSO 4 · 7H 2 O 0.1 g NaCl small amount CaCl 2 small amount FeCl 3 small amount Silicon complex 5 g water 1 liter Medium pH: 3.0 culture Conditions: 30 ° C, 15 days (2) Use of silicon by L.Edodes Medium composition Malt extract 100g Yeast extract 2.5g Ammon tartrate 2.0g Silicon complex 5g Water 1L Medium pH: 4.5 Culture condition: 20 ° C, 15 days culture After completion, the cells are separated from the culture filtrate, and the cells are freeze-pulverized, added with water, extracted with stirring, and centrifuged to remove insolubles. Add ammonium sulfate to the centrifugal supernatant to 50% saturation to produce a precipitate. The precipitate is centrifuged and dried to obtain a powder of the silicon complex protein. On the other hand, 2
A double volume of ethanol is added to form a precipitate, which is separated by filtration and dried to obtain a powder of the silicon complex polysaccharide protein.

以下、Asp.Oryzaeによる珪素複合体を珪素複合蛋白質
−AO、珪素複合多糖蛋白質−AOと記載し、L.Edodesによ
る珪素複合体を珪素複合蛋白質−LE、珪素複合多糖蛋白
質−LEと記載する。それぞれの理化学的性質を下記の表
1に示す。
Hereinafter, the silicon complex according to Asp. Oryzae is described as silicon complex protein-AO and silicon complex polysaccharide protein-AO, and the silicon complex according to L. Edodes is described as silicon complex protein-LE and silicon complex polysaccharide protein-LE. The respective physicochemical properties are shown in Table 1 below.

なお、食品材料として用いる場合には、菌体を凍結し
粉砕した後、瀘液と混合し、そのまま用いるか、用途に
よっては、濃縮及び乾燥して用いることも可能である。
When used as a food material, the cells can be frozen and pulverized, mixed with a filtrate, and used as it is, or, depending on the application, concentrated and dried.

上記のようにして得られた珪素複合蛋白質又は珪素複
合多糖蛋白質からなる抗変異原性物質は、栄養剤とし
て、或いは、他の食品に入れて栄養強化剤として用いる
ことができる。これらはいろいろな形で摂取することも
できるが、通常、液状のものよりも固型化して粉末とす
るのが好ましい。例えば、毎日食事毎に採取し続けるこ
とが有効である。その効果は比較的速効性であり、また
早く排泄される。
The antimutagenic substance comprising the silicon complex protein or the silicon complex polysaccharide protein obtained as described above can be used as a nutritional supplement or as a nutritional enhancer in other foods. These can be ingested in various forms, but it is generally preferable to solidify them into powders rather than liquid ones. For example, it is effective to continue sampling every meal every day. The effect is relatively fast acting and is excreted quickly.

前記のように、癌の発生原因のほとんどは生活環境の
中の二次発癌物質によると考えられているが、上記珪素
複合蛋白質又は珪素複合多糖蛋白質からなる抗変異原性
物質は後述の試験結果から明らかなように化学発癌物質
を無毒化して高い率で癌を予防することができる。
As described above, most of the causes of cancer occurrence are thought to be due to secondary carcinogens in the living environment, but the above-mentioned anti-mutagenic substances composed of the silicon complex protein or the silicon complex polysaccharide protein have the following test results. As is clear from the above, the chemical carcinogen can be detoxified to prevent cancer at a high rate.

一般に、これら二次発癌物質はそれ自体は発癌性を有
していないが、生体の中で代謝されて発癌性を発揮する
物質で加水分解、還元、酸化、抱合等により導入され
る。
In general, these secondary carcinogens do not themselves have carcinogenicity, but are metabolized in the living body and exhibit carcinogenicity, and are introduced by hydrolysis, reduction, oxidation, conjugation and the like.

上記のようにして得られた抗変異原性物質の活性は、
生活環境にある従来既知の二次発癌物質について検討さ
れる。
The activity of the anti-mutagenic substance obtained as described above is
Previously known secondary carcinogens in the living environment will be examined.

本発明では、アゾ色素たるジメチルアミノアゾベンゼ
ン(DAB)、焼け焦げに含まれるベンゾピレン、タバコ
のタール中に含まれるジアルキルニトロソアミンの3種
類の発癌性物質について細菌を用いて突然変異性試験に
より上記珪素複合淡白質、珪素複合多糖蛋白質の抗変異
原性活性を次のようにして測定する。
In the present invention, the above-mentioned silicon complex pale white is subjected to a mutagenicity test using bacteria for three kinds of carcinogens such as azo dye dimethylaminoazobenzene (DAB), benzopyrene contained in scorch, and dialkylnitrosamine contained in tobacco tar. And the antimutagenic activity of the silicon-conjugated polysaccharide protein are measured as follows.

Ames test を用いた実験 Amesらによって分離されたサルモネラ株のうちTA100
株を用いた。
Experiment using Ames test Among Salmonella strains isolated by Ames et al., TA100
The strain was used.

−80℃で保存されているTA100株を融解、遠心洗浄し
た後、同容量の1/15Mリン酸緩衝液(pH7.0)中に浮遊さ
せた。軟寒天液(0.6%寒天末、0.6%NaCl)に0.5mM、
ビオチン−0.5mM、ヒスチジン溶液を1/10容量加えた。
薬物代謝酵素系のために、SD系ラット雄(6週令、平均
178g)の肝磨砕液を常法に従い作成して反応液に加え
た。
The TA100 strain stored at -80 ° C was thawed, centrifugally washed, and then suspended in the same volume of a 1 / 15M phosphate buffer (pH 7.0). 0.5 mM in soft agar solution (0.6% agar powder, 0.6% NaCl)
Biotin-0.5 mM, histidine solution was added at 1/10 volume.
SD rat male (6 weeks old, average)
178 g) of the liver trituration solution was prepared according to a conventional method and added to the reaction solution.

実験に用いた反応液(S−9Mix)1ml中の組成を下記
に示す。
The composition in 1 ml of the reaction solution (S-9Mix) used in the experiment is shown below.

0.3ml 肝磨砕液 8mM MgCl2 33mM KCl 5mM グルコース6リン酸 4mM NADP+ 100mM Na−リン酸緩衝液(pH7.4) 菌液0.1ml、変異原液0.2ml、珪素複合物0.2ml、S−9
Mix0.5mlを加え、37℃で20分間感作後、軟寒天液2mlを
加えて最少寒天培地上に拡げた。
0.3 ml Liver attrition 8 mM MgCl 2 33 mM KCl 5 mM Glucose 6-phosphate 4 mM NADP + 100 mM Na-phosphate buffer (pH 7.4) Bacterial solution 0.1 ml, Mutagen solution 0.2 ml, Silicon complex 0.2 ml, S-9
After adding 0.5 ml of Mix and sensitizing at 37 ° C. for 20 minutes, 2 ml of soft agar was added and spread on a minimal agar medium.

37℃で2日間培養した後、復帰変異コロニー数を測定
した。対照としては珪素複合物の代わりに100mM Na−
リン酸緩衝液を用いた。
After culturing at 37 ° C for 2 days, the number of revertant colonies was measured. As a control, 100 mM Na-
A phosphate buffer was used.

その結果を表2に示す。 Table 2 shows the results.

上記の結果から、いずれの珪素複合物、いずれの発癌
物質の場合も対照に比して復帰変異コロニー数はかなり
少なくなっており、濃度の大なる程その傾向が大であ
る。従っていずれの珪素複合物も各変異原物質に対して
強い抗変異原性活性を示していることが明らかである。
From the above results, the number of revertant colonies is significantly smaller in any of the silicon composites and in any of the carcinogens than in the control, and the tendency increases as the concentration increases. Therefore, it is clear that each of the silicon complexes shows strong antimutagenic activity against each mutagen.

これらの作用は、 変異原に対して修飾不活性化する。 These effects modify and inactivate mutagens.

変異原物質と吸着して変異原作用を抑制する。 Adsorbs mutagenic substances and suppresses mutagenic effects.

等が考えられる。And so on.

〔発明の効果〕〔The invention's effect〕

上記詳述のところから明らかなように、本発明の珪素
をアスペルギルス層又はレンティナス属(シイタケ)か
ら選ばれた糸状菌の培養液中で資化することにより得ら
れた珪素複合蛋白質及び珪素複合多糖蛋白質は優れた抗
変異原性を有しており、常時摂取して生活環境中におけ
る発癌物質を無毒化することができるので、誠に有用で
ある。
As is apparent from the above detailed description, the silicon complex protein and silicon complex polysaccharide obtained by assimilating the silicon of the present invention in the culture medium of Aspergillus layer or a filamentous fungus selected from Lentinus (Shiitake). Proteins have excellent antimutagenicity and can be taken at all times to detoxify carcinogens in the living environment, so they are very useful.

フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:69) (C12P 21/00 C12R 1:645) Continuation of the front page (51) Int.Cl. 6 Identification number Agency reference number FI Technical display location C12R 1:69) (C12P 21/00 C12R 1: 645)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】珪素をアスペルギルス属又はレンティナス
属(シイタケ)から選ばれた糸状菌の培養液中で資化す
ることを特徴とする珪素複合蛋白質及び珪素複合多糖蛋
白質の製造方法。
1. A method for producing a silicon complex protein and a silicon complex polysaccharide protein, wherein silicon is assimilated in a culture solution of a filamentous fungus selected from the genus Aspergillus or Lentinus (Shitatake).
【請求項2】糸状菌に資化させる珪素は錯塩である請求
項1に記載の珪素複合蛋白質及び珪素複合多糖蛋白質の
製造方法。
2. The method according to claim 1, wherein the silicon assimilated by the filamentous fungus is a complex salt.
JP1319458A 1989-12-08 1989-12-08 Method for producing silicon complex protein and silicon complex polysaccharide protein Expired - Lifetime JP2602966B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1319458A JP2602966B2 (en) 1989-12-08 1989-12-08 Method for producing silicon complex protein and silicon complex polysaccharide protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1319458A JP2602966B2 (en) 1989-12-08 1989-12-08 Method for producing silicon complex protein and silicon complex polysaccharide protein

Publications (2)

Publication Number Publication Date
JPH03180191A JPH03180191A (en) 1991-08-06
JP2602966B2 true JP2602966B2 (en) 1997-04-23

Family

ID=18110427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1319458A Expired - Lifetime JP2602966B2 (en) 1989-12-08 1989-12-08 Method for producing silicon complex protein and silicon complex polysaccharide protein

Country Status (1)

Country Link
JP (1) JP2602966B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188647A1 (en) * 1994-05-02 1995-11-09 Stewart Anthony Cederholm-Williams Recombinant fibrin chains, fibrin and fibrin-homologs

Also Published As

Publication number Publication date
JPH03180191A (en) 1991-08-06

Similar Documents

Publication Publication Date Title
Grimm et al. Promotion by zinc of the formation of cytochromes in Ustilago sphaerogena
US6159466A (en) Aqueous composition comprising saccharomyces boulardii sequelaand chromium glycinate dinicotinate
JP3876046B2 (en) Novel phytase and method for producing the same
US3985869A (en) Dental caries-inducing microorganism cells lytic enzyme
JP2602966B2 (en) Method for producing silicon complex protein and silicon complex polysaccharide protein
JPH04126079A (en) Carboxypeptidase b-like enzyme originated from microorganism
DE2166462C3 (en)
US4436725A (en) Physiologically active novel substance mutastein and process for its production
Jensen Decomposition of Keratin by Soil Micro-Organisms (With One Text-figure.)
DE2120930A1 (en) Pepsin inhibitor and process for its preparation
DE2166462B2 (en) 7 BETA - (D-5-AMINO-5-CARBOXYVALERAMIDO) -3- (ALPHA-METHOXY-CINNAMOYLOXYMETHYL) -7-METHOXY-3-CEPHEM-4-CARBONIC ACID COMPOUNDS, METHODS FOR THEIR PRODUCTION AND ARNEIMAL COMPOUNDS
JPH044874A (en) Fructosylamino acid hydrolase, production and utilization thereof
EP0035742B1 (en) Homocitric acid oligoriboside derivatives, process for their manufacture and their use as preventives of dental caries
KR960016134B1 (en) Manufacturing method of red pigment by microorganism
CH641837A5 (en) BETA GALACTOSIDASE AND METHOD FOR THE PRODUCTION THEREOF.
SU503532A3 (en) The method of obtaining the enzyme for lysis of microbial cells
DE3025424C2 (en) Process for the production of galactose oxidase
JPS582671B2 (en) Production method of cholesterin esterase
Jensen Biological transformation of thiourea
Mortenson et al. Appearance of sulfhydryl groups during growth of Bacillus globigii
JPS6326098B2 (en)
JPS5946593B2 (en) Method for producing alkaline protease
JPS6291177A (en) Production of selenium-containing microbial cell
DE3248427A1 (en) METHOD FOR PRODUCING TYRAMINE OXYDASE
KR920005970B1 (en) New microorganism aureobasidicum pullulans sh88104 & sh8897